Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

There are significant questions on how the order can be implemented, and if companies can raise prices on already approved ...

Pfizer's 7.45% dividend yield can't offset weak growth, declining EPS, and patent risks. Read more on PFE and why analysts ...

Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...

Shares of pharmaceutical companies dropped early Monday after President Donald Trump said he would lower the cost of ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these ...

With its stock down 7.6% over the past three months, it is easy to disregard Pfizer (NYSE:PFE). We, however decided ...

The executive order that Donald Trump has signed over the last 24 hours could have a significant effect on pharmaceutical ...

There are worse fates than being a household name, declaring generous quarterly distributions, and being currently out of ...

Amid the ongoing uncertainty about tariffs, muted earnings season, and recession concerns, the stock market has remained ...

With volatility taking center stage since the beginning of the year, investing in the stock market isn’t as easy as it was.